2. Academic Validation
  3. Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists

Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists

  • Bioorg Med Chem Lett. 2002 Dec 2;12(23):3421-4. doi: 10.1016/s0960-894x(02)00736-9.
Gaetan H Ladouceur 1,  James H Cook,  Donald L Hertzog,  J Howard Jones,  Thomas Hundertmark,  Mary Korpusik,  Timothy G Lease,  James N Livingston,  Margit L MacDougall,  Martin H Osterhout,  Kathleen Phelan,  Romulo H Romero,  William R Schoen,  Chunning Shao,  Roger A Smith
Affiliations

Affiliation

  • 1 Department of Chemistry Research, Bayer Research Center, West Haven, CT 06516, USA. gaetan.ladouceur.b@bayer.com
PMID: 12419375 DOI: 10.1016/s0960-894x(02)00736-9
Abstract

Optimized substituent patterns in 4-aryl-pyridine Glucagon Receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1R)-hydroxyethyl] and a 2'-hydroxy group. Due to restricted rotation of the phenyl-pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC(50)=10-25 nM.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z